icon
0%

Veralto Corporation VLTO - News Analyzed: 3,752 - Last Week: 100 - Last Month: 500

↑ Veralto Corporation VLTO: Biotech Giant's Stock is Trading High Amidst Mixed Market Perceptions

Veralto Corporation VLTO: Biotech Giant's Stock is Trading High Amidst Mixed Market Perceptions
An extensive collection of news unveils interesting details about Veralto Corporation (VLTO). The company sold US$795k in stock, alluding to potential frailty. Brokerages have given VLTO an average rating of 'Moderate Buy'. Franklin Resources Inc acquired over 2 million shares while Concourse Financial Group Securities purchased 518 shares. VLTO is to distribute a quarterly dividend of $0.09. Multiple financial groups like Principal Financial Group and Mckinley Capital Management have invested significantly in VLTO while the corporation has delivered a higher than average ROE. The company posted solid year-over-year sales growth and robust free cash flow in the fourth quarter, but there might be some lacking confidence based on the P/S of VLTO. There are also diverse investments in VLTO by companies like Swiss National Bank and Victory Capital Management Inc. VLTO suggests shareholders reject Mini-Tender Offer by TRC Capital Investment Corporation. As of Guideline, Veralto is reaping the benefits of being a public trading company. Meanwhile, VLTO's stock price has hit a new 1-year high at $100.00.

Veralto Corporation VLTO News Analytics from Mon, 31 Oct 2022 14:41:53 GMT to Thu, 23 May 2024 19:38:16 GMT - Rating 7 - Innovation 5 - Rumor -8

The email address you have entered is invalid.